P

Personalis
D

PSNL

3.92000
USD
0.20
(5.38%)
Market Closed
Volume
24,341
EPS
-1
Div Yield
-
P/E
-2
Market Cap
276,940,489
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BEAM
    -2.275
    (-8.65%)
    24.035 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    N
    NTLA
    -1.165
    (-7.71%)
    13.955 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    464.69 USD
    More
News

Title: Personalis

Sector: Healthcare
Industry: Diagnostics & Research
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.